Skip to main content
Erschienen in: Diabetologia 1/2014

01.01.2014 | Article

SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity

verfasst von: Masatoshi Nomura, Hai-Lei Zhu, Lixiang Wang, Hidetaka Morinaga, Ryoichi Takayanagi, Noriyoshi Teramoto

Erschienen in: Diabetologia | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The TGF-β superfamily of ligands provides important signals for the development of pancreas islets. However, it is not yet known whether the TGF-β family signalling pathway is required for essential islet functions in the adult pancreas.

Methods

To identify distinct roles for the downstream components of the canonical TGF-β signalling pathway, a Cre-loxP system was used to disrupt SMAD2, an intracellular transducer of TGF-β signals, in pancreatic beta cells (i.e. Smad2β knockout [KO] mice). The activity of ATP-sensitive K+ channels (KATP channels) was recorded in mutant beta cells using patch-clamp techniques.

Results

The Smad2βKO mice exhibited defective insulin secretion in response to glucose and overt diabetes. Interestingly, disruption of SMAD2 in beta cells was associated with a striking islet hyperplasia and increased pancreatic insulin content, together with defective glucose-responsive insulin secretion. The activity of KATP channels was decreased in mutant beta cells.

Conclusions/interpretation

These results suggest that in the adult pancreas, TGF-β signalling through SMAD2 is crucial for not only the determination of beta cell mass but also the maintenance of defining features of mature pancreatic beta cells, and that this involves modulation of KATP channel activity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kim SK, Hebrok M (2001) Intercellular signals regulating pancreas development and function. Genes Dev 15:111–127PubMedCrossRef Kim SK, Hebrok M (2001) Intercellular signals regulating pancreas development and function. Genes Dev 15:111–127PubMedCrossRef
2.
Zurück zum Zitat Kim SK, MacDonald RJ (2002) Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev 12:540–547PubMedCrossRef Kim SK, MacDonald RJ (2002) Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev 12:540–547PubMedCrossRef
3.
Zurück zum Zitat Massagué J, Blain SW, Lo RS (2000) TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295–309PubMedCrossRef Massagué J, Blain SW, Lo RS (2000) TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103:295–309PubMedCrossRef
4.
Zurück zum Zitat Feng XH, Derynck R (2005) Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 21:659–693PubMedCrossRef Feng XH, Derynck R (2005) Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol 21:659–693PubMedCrossRef
5.
Zurück zum Zitat Massagué J, Chen YG (2000) Controlling TGF-beta signaling. Genes Dev 14:627–644PubMed Massagué J, Chen YG (2000) Controlling TGF-beta signaling. Genes Dev 14:627–644PubMed
6.
Zurück zum Zitat Ogawa K, Abe K, Kurosawa N et al (1993) Expression of alpha, beta A and beta B subunits of inhibin or activin and follistatin in rat pancreatic islets. FEBS Lett 319:217–220PubMedCrossRef Ogawa K, Abe K, Kurosawa N et al (1993) Expression of alpha, beta A and beta B subunits of inhibin or activin and follistatin in rat pancreatic islets. FEBS Lett 319:217–220PubMedCrossRef
7.
Zurück zum Zitat Yamanaka Y, Friess H, Büchler M, Beger HG, Gold LI, Korc M (1993) Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. Diabetes 42:746–756PubMedCrossRef Yamanaka Y, Friess H, Büchler M, Beger HG, Gold LI, Korc M (1993) Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. Diabetes 42:746–756PubMedCrossRef
8.
Zurück zum Zitat Wada M, Shintani Y, Kosaka M, Sano T, Hizawa K, Saito S (1996) Immunohistochemical localization of activin A and follistatin in human tissues. Endocr J 43:375–385PubMedCrossRef Wada M, Shintani Y, Kosaka M, Sano T, Hizawa K, Saito S (1996) Immunohistochemical localization of activin A and follistatin in human tissues. Endocr J 43:375–385PubMedCrossRef
9.
Zurück zum Zitat Yamaoka T, Idehara C, Yano M et al (1998) Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J Clin Invest 102:294–301PubMedCrossRef Yamaoka T, Idehara C, Yano M et al (1998) Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. J Clin Invest 102:294–301PubMedCrossRef
10.
Zurück zum Zitat Florio P, Luisi S, Marchetti P et al (2000) Activin A stimulates insulin secretion in cultured human pancreatic islets. J Endocrinol Investig 23:231–234 Florio P, Luisi S, Marchetti P et al (2000) Activin A stimulates insulin secretion in cultured human pancreatic islets. J Endocrinol Investig 23:231–234
11.
Zurück zum Zitat Totsuka Y, Tabuchi M, Kojima I, Shibai H, Ogata E (1988) A novel action of activin A: stimulation of insulin secretion in rat pancreatic islets. Biochem Biophys Res Commun 156:335–339PubMedCrossRef Totsuka Y, Tabuchi M, Kojima I, Shibai H, Ogata E (1988) A novel action of activin A: stimulation of insulin secretion in rat pancreatic islets. Biochem Biophys Res Commun 156:335–339PubMedCrossRef
12.
Zurück zum Zitat Totsuka Y, Tabuchi M, Kojima I, Eto Y, Shibai H, Ogata E (1989) Stimulation of insulin secretion by transforming growth factor-beta. Biochem Biophys Res Commun 158:1060–1065PubMedCrossRef Totsuka Y, Tabuchi M, Kojima I, Eto Y, Shibai H, Ogata E (1989) Stimulation of insulin secretion by transforming growth factor-beta. Biochem Biophys Res Commun 158:1060–1065PubMedCrossRef
13.
Zurück zum Zitat Kim SK, Hebrok M, Li E et al (2000) Activin receptor patterning of foregut organogenesis. Genes Dev 14:1866–1871PubMed Kim SK, Hebrok M, Li E et al (2000) Activin receptor patterning of foregut organogenesis. Genes Dev 14:1866–1871PubMed
14.
Zurück zum Zitat Nomura M, Li E (1998) Smad2 role in mesoderm formation, left–right patterning and craniofacial development. Nature 393:786–790PubMedCrossRef Nomura M, Li E (1998) Smad2 role in mesoderm formation, left–right patterning and craniofacial development. Nature 393:786–790PubMedCrossRef
15.
Zurück zum Zitat Goto Y, Nomura M, Tanaka K et al (2007) Genetic interactions between activin type IIB receptor and Smad2 genes in asymmetrical patterning of the thoracic organs and the development of pancreas islets. Dev Dyn 236:2865–2874PubMedCrossRef Goto Y, Nomura M, Tanaka K et al (2007) Genetic interactions between activin type IIB receptor and Smad2 genes in asymmetrical patterning of the thoracic organs and the development of pancreas islets. Dev Dyn 236:2865–2874PubMedCrossRef
16.
Zurück zum Zitat Zhang Y-Q, Kanzaki M, Furukawa M et al (1999) Involvement of Smad proteins in the differentiation of pancreatic AR42J cells induced by activin A. Diabetologia 42:719–727PubMedCrossRef Zhang Y-Q, Kanzaki M, Furukawa M et al (1999) Involvement of Smad proteins in the differentiation of pancreatic AR42J cells induced by activin A. Diabetologia 42:719–727PubMedCrossRef
17.
Zurück zum Zitat Smart NG, Apelqvist ÅA, Gu X et al (2006) Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol 4(e39):0200–0209 Smart NG, Apelqvist ÅA, Gu X et al (2006) Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus. PLoS Biol 4(e39):0200–0209
18.
Zurück zum Zitat Lin HM, Lee JH, Yadav H et al (2009) Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem 284:12246–12257PubMedCrossRef Lin HM, Lee JH, Yadav H et al (2009) Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem 284:12246–12257PubMedCrossRef
19.
Zurück zum Zitat Wang L, Nomura M, Goto Y et al (2011) Smad2 protein disruption in the central nervous system leads to aberrant cerebellar development and early postnatal ataxia in mice. J Biol Chem 286:18766–18774PubMedCrossRef Wang L, Nomura M, Goto Y et al (2011) Smad2 protein disruption in the central nervous system leads to aberrant cerebellar development and early postnatal ataxia in mice. J Biol Chem 286:18766–18774PubMedCrossRef
20.
Zurück zum Zitat Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35–39PubMed Lacy PE, Kostianovsky M (1967) Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35–39PubMed
21.
Zurück zum Zitat Fan W, Yanase T, Nomura M et al (2005) Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54:1000–1008PubMedCrossRef Fan W, Yanase T, Nomura M et al (2005) Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54:1000–1008PubMedCrossRef
22.
Zurück zum Zitat Teramoto N, Zhu HL, Shibata A et al (2009) ATP-sensitive K+ channels in pig urethral smooth muscle cells are heteromultimers of Kir6.1 and Kir6.2. Am J Physiol 296:F107–F117 Teramoto N, Zhu HL, Shibata A et al (2009) ATP-sensitive K+ channels in pig urethral smooth muscle cells are heteromultimers of Kir6.1 and Kir6.2. Am J Physiol 296:F107–F117
23.
Zurück zum Zitat Valassi E, Scacchi M, Cavagnini F (2008) Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 18:158–168PubMedCrossRef Valassi E, Scacchi M, Cavagnini F (2008) Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis 18:158–168PubMedCrossRef
24.
Zurück zum Zitat Sainsbury A, Zhang L (2012) Role of the hypothalamus in the neuroendocrine regulation of body weight and composition during energy deficit. Obes Rev 13:234–257PubMedCrossRef Sainsbury A, Zhang L (2012) Role of the hypothalamus in the neuroendocrine regulation of body weight and composition during energy deficit. Obes Rev 13:234–257PubMedCrossRef
25.
Zurück zum Zitat Ahlgren U, Jonsson J, Edlund H (1996) The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122:1409–1416PubMed Ahlgren U, Jonsson J, Edlund H (1996) The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122:1409–1416PubMed
26.
Zurück zum Zitat Bertolino P, Holmberg R, Reissmann E, Andersson O, Berggren PO, Ibáñez CF (2008) Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proc Natl Acad Sci U S A 105:7246–7251PubMedCrossRef Bertolino P, Holmberg R, Reissmann E, Andersson O, Berggren PO, Ibáñez CF (2008) Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proc Natl Acad Sci U S A 105:7246–7251PubMedCrossRef
27.
Zurück zum Zitat Zhao F, Huang F, Tang M et al (2012) Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 β-cells. Am J Physiol Endocrinol Metab 303:E132–E143PubMedCrossRef Zhao F, Huang F, Tang M et al (2012) Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 β-cells. Am J Physiol Endocrinol Metab 303:E132–E143PubMedCrossRef
28.
Zurück zum Zitat Mukherjee A, Sidis Y, Mahan A et al (2007) FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci U S A 104:1348–1353PubMedCrossRef Mukherjee A, Sidis Y, Mahan A et al (2007) FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci U S A 104:1348–1353PubMedCrossRef
29.
Zurück zum Zitat Harmon EB, Apelqvist AA, Smart NG, Gu X, Osborne DH, Kim SK (2004) GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development 131:6163–6174PubMedCrossRef Harmon EB, Apelqvist AA, Smart NG, Gu X, Osborne DH, Kim SK (2004) GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development. Development 131:6163–6174PubMedCrossRef
30.
Zurück zum Zitat McPherron AC (2010) Metabolic functions of myostatin and GDF11. Immunol Endocr Metab Agents Med Chem 10:217–231PubMedCrossRef McPherron AC (2010) Metabolic functions of myostatin and GDF11. Immunol Endocr Metab Agents Med Chem 10:217–231PubMedCrossRef
31.
Zurück zum Zitat Aguilar-Bryan L, Bryan J (1999) Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101–135PubMedCrossRef Aguilar-Bryan L, Bryan J (1999) Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101–135PubMedCrossRef
32.
Zurück zum Zitat Seino S (1999) ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 61:337–362PubMedCrossRef Seino S (1999) ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 61:337–362PubMedCrossRef
Metadaten
Titel
SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity
verfasst von
Masatoshi Nomura
Hai-Lei Zhu
Lixiang Wang
Hidetaka Morinaga
Ryoichi Takayanagi
Noriyoshi Teramoto
Publikationsdatum
01.01.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 1/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3062-2

Weitere Artikel der Ausgabe 1/2014

Diabetologia 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.